BUSINESS● LOWAug 12 · Aug 12, 2026, 8:33 PM
Reviva Pharmaceuticals GAAP EPS of -$0.19 beats by $0.17
Seeking Alpha Tech
Reviva Pharmaceuticals reported GAAP EPS of -$0.19, which beat expectations by $0.17. This indicates the company's financial performance exceeded analyst expectations for the period.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS46m agoChina financial regulators roll out targeted policies at key financial forum , reaffirm opening - upglobaltimes.cn · ChinaBUSINESS46m agoFortum scraps charging network business sale deal to JBM Group promoterslivemint.com · India